• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, March 3, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS

Bionic eye approved

Bioengineer by Bioengineer
August 30, 2013
in NEWS
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The system consists of a small video camera and transmitter mounted on eyeglasses. The camera processes images into electronic data that is wirelessly transmitted to electrodes implanted into the retina.

bioniceye

The device will not fully restore patients’ vision, but the FDA said Thursday that “it may allow them to detect light and dark in the environment.”
 
The journal MedGadget writes that patients “who could barely detect an extremely bright light, have reported the ability to recognize large letters and locate positions of household objects” using the Argus II.
 
The device had already been approved in Europe.
 
The FDA approval came under the “humanitarian use” category, which is limited to devices that annually treat or diagnose fewer than 4,000 people in the United States. Retinitis pigmentosa affects one in every 4,000 Americans.
 
“This is a game changer in sight-affecting diseases that represents a huge step forward for the field and for these patients who were without any available treatment options until now,” said Robert Greenberg, president and CEO of Second Sight.
 
Serendipitously, a Popular Science writer happened to be interviewing the company’s vice president Thursday morning when he learned of the FDA’s decision.
 
The breakthrough comes after more than 20 years, two clinical trials, more than $100 million in public monies (from the National Eye Institute, Energy Department and National Science Foundation) and $100 million in private investments.
 
But, as MedGadget notes, there’s competition.
 
A similar device from Israel-based Bio-Retina reportedly provides nearly 600-pixel clarity, and the company is aiming to develop a 5000-pixel device.

Story Source:

The above story is reprinted from materials provided by USATODAY. The original article was written by Michael Winter.

Tags: Bionic eye
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

University students with special educational needs highlight the benefits of e-assessment

March 3, 2021
IMAGE

Key steps discovered in production of critical immune cell

March 3, 2021

Researchers discover SARS-CoV-2 inhibitors

March 3, 2021

‘Target identified’: teaching a machine how to identify imperfections in 2D materials

March 3, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    661 shares
    Share 264 Tweet 165
  • People living with HIV face premature heart disease and barriers to care

    83 shares
    Share 33 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

BiologyInfectious/Emerging DiseasesMedicine/HealthClimate ChangeGeneticsPublic HealthTechnology/Engineering/Computer ScienceCell BiologycancerMaterialsChemistry/Physics/Materials SciencesEcology/Environment

Recent Posts

  • University students with special educational needs highlight the benefits of e-assessment
  • Key steps discovered in production of critical immune cell
  • Researchers discover SARS-CoV-2 inhibitors
  • ‘Target identified’: teaching a machine how to identify imperfections in 2D materials
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In